Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Receivables (2017 - 2025)

Organogenesis Holdings has reported Receivables over the past 9 years, most recently at $217.5 million for Q4 2025.

  • Quarterly results put Receivables at $217.5 million for Q4 2025, up 82.06% from a year ago — trailing twelve months through Dec 2025 was $217.5 million (up 82.06% YoY), and the annual figure for FY2025 was $217.5 million, up 82.06%.
  • Receivables for Q4 2025 was $217.5 million at Organogenesis Holdings, up from $182.2 million in the prior quarter.
  • Over the last five years, Receivables for ORGO hit a ceiling of $217.5 million in Q4 2025 and a floor of $72.0 million in Q1 2021.
  • Median Receivables over the past 5 years was $96.3 million (2022), compared with a mean of $105.8 million.
  • Biggest five-year swings in Receivables: soared 120.03% in 2021 and later dropped 9.54% in 2023.
  • Organogenesis Holdings' Receivables stood at $87.6 million in 2021, then rose by 2.1% to $89.4 million in 2022, then decreased by 8.33% to $82.0 million in 2023, then skyrocketed by 45.66% to $119.4 million in 2024, then skyrocketed by 82.06% to $217.5 million in 2025.
  • The last three reported values for Receivables were $217.5 million (Q4 2025), $182.2 million (Q3 2025), and $120.4 million (Q2 2025) per Business Quant data.